Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Randomized, Two-armed, Parallel Group and Evaluator-blinded Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

NCT02866032 is registered in ClinicalTrials.gov with Moberg Pharma AB as lead sponsor.

NCT NCT02866032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Randomized, Two-armed, Parallel Group and Evaluator-blinded Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Lead sponsor
Moberg Pharma AB
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2016
Completion date
June 10, 2020
Enrollment
452 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

distal subungual onychomycosis